| Keywords: |
cancer chemotherapy; child; treatment outcome; treatment response; clinical feature; pathogenesis; review; antineoplastic agents; cancer radiotherapy; cancer staging; human immunodeficiency virus infection; nuclear magnetic resonance imaging; positron emission tomography; magnetic resonance imaging; antineoplastic agent; cancer diagnosis; cancer incidence; neoplasm staging; radiopharmaceuticals; disease association; computer assisted tomography; mantle cell lymphoma; tomography, x-ray computed; age factors; central nervous system tumor; childhood cancer; hodgkin disease; central nervous system; cause of death; symptom; lymphoma, b-cell; peripheral t cell lymphoma; antibodies, monoclonal; nonhodgkin lymphoma; lymphoma, non-hodgkin; splenomegaly; fluorodeoxyglucose f18; positron-emission tomography; remission induction; world health organization; acquired immune deficiency syndrome; large cell lymphoma; kaposi sarcoma; thyroid gland; immunosuppressive treatment; follicular lymphoma; parotid gland; lymphadenopathy; helicobacter pylori; burkitt lymphoma; epstein barr virus; human herpesvirus 8; pleura disease; organ transplantation; primary effusion lymphoma; mucosa associated lymphoid tissue lymphoma; immunoglobulin a deficiency
|
